Urazova L N, Gromova A I
Research Institute of Oncology, Research Center, Russian Academy of Medical Sciences, Siberian Branch, Tomsk.
Vopr Onkol. 2001;47(1):78-80.
The potential of therapy with vaccinal strain of Venezuelan encephalomyelitis virus (VEL) in conjunction with cytostatics (cyclophosphamide) or immunomodulators (T-activin) has been studied. It was found that VEL in conjunction with cyclophosphamide inhibited the antitumor action of the drugs while T-activin potentiated the same effects of the virus and its oncolysate.
对委内瑞拉马脑炎病毒(VEL)疫苗株与细胞抑制剂(环磷酰胺)或免疫调节剂(T-激活素)联合进行治疗的潜力进行了研究。结果发现,VEL与环磷酰胺联合使用会抑制药物的抗肿瘤作用,而T-激活素则增强了病毒及其肿瘤溶解产物的相同作用。